ArticleDiabetes, obesity & metabolism2026

Safety Signals of GLP-1 Receptor Agonists: A Multi-Method Pharmacovigilance Analysis of FAERS (2018-2025) With Sensitivity-Stratified Prioritisation, Notoriety-Bias Assessment, and Cross-Database Validation.

Shiyi XuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.